135 related articles for article (PubMed ID: 591295)
1. Viroimmunoassay utilizing a synthetic peptide: a test equivalent to the carcinoembryonic antigen radioimmunoassay.
Arnon R; Novik N; Haimovich J; Chaitchik S
Isr J Med Sci; 1977 Oct; 13(10):1022-7. PubMed ID: 591295
[TBL] [Abstract][Full Text] [Related]
2. Use of a passive hemagglutination inhibition test for monitoring levels of serum carcinoembryonic antigen following surgical therapy.
Anthony RL; Sosnowski KM
Ann Clin Lab Sci; 1976; 6(2):130-6. PubMed ID: 943151
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of elevated anti-Lewis antibodies in sera of cancer patients using a carcinoembryonic antigen-polyethylene glycol immunoassay.
Pompecki R; Shively JE; Todd CW
Cancer Res; 1981 May; 41(5):1910-5. PubMed ID: 6163531
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody CIBCHTB1 defining an epitope on carcinoembryonic antigen (CEA).
Meenakshi A; Kumar NS; Vijayshanker SG
Hum Antibodies; 2000; 9(4):223-9. PubMed ID: 11341176
[TBL] [Abstract][Full Text] [Related]
5. Adjunct to the diagnostic distinction between adenocarcinomas of the ovary and the colon utilizing a monoclonal antibody (COL-4) with restricted carcinoembryonic antigen reactivity.
Thor A; Muraro R; Gorstein F; Ohuchi N; Viglione M; Szpak CA; Johnston WW; Schlom J
Cancer Res; 1987 Jan; 47(2):505-12. PubMed ID: 2431771
[TBL] [Abstract][Full Text] [Related]
6. Carcinoembryonic (CEA)--like antigen in adenomas and cancers of the breast in human patients.
Potomski J; Harlozińska A; Richter R; Starzyk H
Arch Immunol Ther Exp (Warsz); 1979; 27(4):461-8. PubMed ID: 92973
[TBL] [Abstract][Full Text] [Related]
7. [The CEA test and other immunological tests as disease course controls in gastrointestinal adenocarcinoma].
Hasler E; Spengler A; Berchtold R; Brunner KW; de Weck A
Schweiz Med Wochenschr; 1977 Nov; 107(47):1683-91. PubMed ID: 929129
[TBL] [Abstract][Full Text] [Related]
8. Immunological cross-reactivity of antibodies to a synthetic undecapeptide analogous to the amino terminal segment of carcinoembryonic antigen, with the intact protein and with human sera.
Arnon R; Bustin M; Calef E; Chaitchik S; Haimovich J; Novik N; Sela M
Proc Natl Acad Sci U S A; 1976 Jun; 73(6):2123-7. PubMed ID: 1064879
[TBL] [Abstract][Full Text] [Related]
9. Circulating carcinoembryonic antigen immune complexes in sera of patients with carcinomata of the gastrointestinal tract.
Kapsopoulou-Dominos K; Anderer FA
Clin Exp Immunol; 1979 Feb; 35(2):190-5. PubMed ID: 108040
[TBL] [Abstract][Full Text] [Related]
10. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
Tappero G; Piantino P; Cerchier A; Pecchio F
Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen].
Olsson NO; Crimet-Montange D; Martin F
Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449
[TBL] [Abstract][Full Text] [Related]
12. Preparation and specificities of antisera to the amino-terminal sequence of the carcinoembryonic antigen.
Paul D; Flouret G; Tomita JT; Ranney K; Schenck J; Anderson B
Cancer Res; 1981 Jun; 41(6):2315-21. PubMed ID: 7237430
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.
Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW
Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
Ueda Y; Itoh T; Nukaya I; Kawashima I; Okugawa K; Yano Y; Yamamoto Y; Naitoh K; Shimizu K; Imura K; Fuji N; Fujiwara H; Ochiai T; Itoi H; Sonoyama T; Hagiwara A; Takesako K; Yamagishi H
Int J Oncol; 2004 Apr; 24(4):909-17. PubMed ID: 15010829
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
[TBL] [Abstract][Full Text] [Related]
16. An approach to the routine estimation of circulating carcinoembryonic antigen immune complexes in patients with carcinomata of the gastrointestinal tract.
Kapsopoulou-Dominos K; Anderer FA
Clin Exp Immunol; 1979 Jul; 37(1):25-32. PubMed ID: 226300
[TBL] [Abstract][Full Text] [Related]
17. Tumor concentration and distribution of carcinoembryonic antigen measured by in vitro quantitative autoradiography.
Chung JK; Jang JJ; Lee DS; Lee MC; Koh CS
J Nucl Med; 1994 Sep; 35(9):1499-505. PubMed ID: 8071700
[TBL] [Abstract][Full Text] [Related]
18. Immunological diagnosis of pancreatic cancer by assaying carcinoembryonic antigen (CEA) in pure pancreatic juice.
Nishida K; Yoshikawa T; Kondo M; Thiele HG
Hepatogastroenterology; 1980 Dec; 27(6):488-94. PubMed ID: 7203382
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of circulating immune complexes of carcinoembryonic antigen (CEA) in patients with adenocarcinoma of the gastrointestinal tract (author's transl)].
Staab HJ; Anderer FA; Stumpf E; Fischer R
J Clin Chem Clin Biochem; 1980 Mar; 18(3):175-81. PubMed ID: 7381371
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
